Cooperative Group Clinical Trials in General Thoracic Surgery: Report From the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical.

Slides:

Advertisements

Similar presentations

Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography.

Advertisements

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Thomas J. Birdas, MD, Richard P. M

Bryan L. Walker, BS, Christina Williamson, MD, Shawn M

Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society.

Chun Chieh Lin, PhD, MBA, Matthew P

Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer Shenhai Wei, MD, PhD,

Joshua E. Rosen, BASc, Hari B

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Sameer A. Hirji, BS, John C. Haney, MD, Ian Welsby, MD, Frederick W

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

The True False Negative Rates of Esophageal and Endobronchial Ultrasound in the Staging of Mediastinal Lymph Nodes in Patients With Non-Small Cell Lung.

Feasibility and Safety of Nonintubated Thoracoscopic Lobectomy for Geriatric Lung Cancer Patients Chun-Yu Wu, MD, Jin-Shing Chen, MD, PhD, Yi-Shiuan.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

When is it Best to Repeat a 2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Scan on Patients with Non-Small Cell Lung Cancer.

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Cyclooxygenase-2 Expression in Non-Small Cell Lung Cancer Correlates With Hypertrophic Osteoarthropathy Ioannis Rotas, Giovanni Cito, Igor Letovanec,

K. Robert Shen, MD, Mark S. Allen, MD, Stephen D

A Randomized Controlled Trial of Bupivacaine Through Intracostal Catheters for Pain Management After Thoracotomy Mark S. Allen, MD, Lisa Halgren, RN,

Adil Ayub, MD, Sadiq S. Rehmani, MD, Adnan M

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

The Efficacy of Restaging Endobronchial Ultrasound in Patients With Non-Small Cell Lung Cancer After Preoperative Therapy Basil S. Nasir, MBBCh, Ayesha.

Positron Emission Tomography-Computed Tomography for Postoperative Surveillance in Non-Small Cell Lung Cancer Se Hoon Choi, MD, Young Tae Kim, MD, PhD,

Surgical Resection of a Giant Coronary Aneurysm

Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,

Pleural Metastasis of Osteosarcoma

Surgical Repair of a Chronic Traumatic Sternal Fracture

Theolyn N. Price, MD, Mark S. Allen, MD, Francis C

Surgical Resection of Rare Esophageal Cancers

Thomas J. Birdas, MD, Richard P. M

Origins of the Cardiothoracic Surgery Network (CTSNet)

Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer Pamela Samson, MD, MPHS, Traves.

Who Do You Say You Are? The Annals of Thoracic Surgery

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival Pamela Samson, MD, MPHS, Traves.

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer Stephen A. Barnett, MBBS, Robert.

Use of Amiodarone After Major Lung Resection

Abel Gómez-Caro, MD, Pedro Arguis, MD The Annals of Thoracic Surgery

Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database Mark Onaitis,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Differentiating N0 Versus N1 Lung Cancer Kazuhiro Yasufuku, MD, PhD, Takahiro Nakajima,

Editorial Board, January 2010

Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD

Zaid M. Abdelsattar, MD, MS, K

Sequential Design for Clinical Trials Evaluating a Prosthetic Heart Valve Cody Hamilton, PhD, Michael Lu, PhD, Steven Lewis, PhD, William Anderson, PhD

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Bullectomy for Symptomatic or Complicated Giant Lung Bullae

Robert Lee Replogle, September 30, 1931–May 9, 2016

The American Board of Thoracic Surgery: Update

Phase I/II Trial of Hyperfractionated Radiation and Chemotherapy Followed by Surgery in Stage III Lung Cancer Martin J. Edelman, MD, Mohan Suntharalingam,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Induction Therapy Followed by Surgery for T3-T4/N0 Non-Small Cell Lung Cancer: Long-Term Results Filippo Lococo, MD, Alfredo Cesario, MD, Stefano Margaritora,

Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base

Meghan R. Flanagan, MD, Thomas K. Varghese, MD, MS, Leah M

Presentation transcript:

Cooperative Group Clinical Trials in General Thoracic Surgery: Report From the 2012 Robert Ginsberg Clinical Trials Meeting of the General Thoracic Surgical Club Mark S. Allen, MD, Dennis A. Wigle, MD, PhD The Annals of Thoracic Surgery Volume 95, Issue 2, Pages 750-756 (February 2013) DOI: 10.1016/j.athoracsur.2012.10.085 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Schema for ACOSOG Z4099/RTOG 1021. (NSCLC = non-small cell lung cancer.) The Annals of Thoracic Surgery 2013 95, 750-756DOI: (10.1016/j.athoracsur.2012.10.085) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Schema for CALGB 140503. (NSCLC = non-small cell lung cancer; Rx = therapy; XRT = radiation therapy.) The Annals of Thoracic Surgery 2013 95, 750-756DOI: (10.1016/j.athoracsur.2012.10.085) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Schema for RTOG 0839. (NSCLC = non-small cell lung cancer.) The Annals of Thoracic Surgery 2013 95, 750-756DOI: (10.1016/j.athoracsur.2012.10.085) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Schema for ECOG 1505. (NSCLC = non-small cell lung cancer.) The Annals of Thoracic Surgery 2013 95, 750-756DOI: (10.1016/j.athoracsur.2012.10.085) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Schema for RTOG 1010. (HER2 = herceptin 2 receptor; XRT = radiation therapy.) The Annals of Thoracic Surgery 2013 95, 750-756DOI: (10.1016/j.athoracsur.2012.10.085) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 6 Schema for CALGB 80803/RTOG 1175. (Chemo = chemotherapy; CT = computed tomography; PET = proton emission tomography; XRT = radiation therapy.) The Annals of Thoracic Surgery 2013 95, 750-756DOI: (10.1016/j.athoracsur.2012.10.085) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 7 Schema for NCCTG N0849. (XRT = radiation therapy.) The Annals of Thoracic Surgery 2013 95, 750-756DOI: (10.1016/j.athoracsur.2012.10.085) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 8 Schema for TOP GEAR. (EGJ = esophagogastric junction; XRT = radiation therapy.) The Annals of Thoracic Surgery 2013 95, 750-756DOI: (10.1016/j.athoracsur.2012.10.085) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions